Ryan Kramer

Ryan Kramer Email and Phone Number

Leader in Drug Product Design and Development; Vaccines, LNPs, Adjuvants, Biologics, Fill/Finish, early-stage through commercial development @ AstraZeneca
Ryan Kramer's Location
Greater Seattle Area, United States, United States
Ryan Kramer's Contact Details
About Ryan Kramer

Ryan Kramer is a Leader in Drug Product Design and Development; Vaccines, LNPs, Adjuvants, Biologics, Fill/Finish, early-stage through commercial development at AstraZeneca. He possess expertise in protein chemistry, protein expression, protein purification, biochemistry, life sciences and 24 more skills.

Ryan Kramer's Current Company Details
AstraZeneca

Astrazeneca

View
Leader in Drug Product Design and Development; Vaccines, LNPs, Adjuvants, Biologics, Fill/Finish, early-stage through commercial development
Ryan Kramer Work Experience Details
  • Astrazeneca
    Director, Vaccines & Immune Therapies
    Astrazeneca May 2024 - Present
    Cambridge, Cambridgeshire, Gb
  • Venture-Backed Newco
    Senior Director, Formulation Development
    Venture-Backed Newco Dec 2023 - May 2024
  • Pfizer
    Principal Scientist, Drug Product Design And Development
    Pfizer Sep 2021 - Dec 2023
    New York, New York, Us
    • Drug product development lead in a highly-matrixed organization responsible for phase 1 though post-commercial support for antibodies, vaccines, and gene therapies.• Drug product lead for three exploratory phase 1 clinical studies leading to submission of two INDs and one IMPD. • Led the development of a multi-dose vial presentation for a commercialized vaccine from conceptualization through process validation and BLA/MAA authoring.• Established mRNA + LNP capabilities at the Chesterfield site. Recruited and led the tech transfer team in establishing analytical and fabrication methods including strategy, facility build-out, personnel training, and verification of site-to-site equivalence.• First LNP drug product lead at Chesterfield site with expected IND submission in 2024. • Member of the LNP regulatory document review team responsible for reviewing LNP regulatory filings for consistency across programs.• Member of a limited duration team focused on evaluating tissue-targeting technologies for gene editing using lipid nanoparticle and other delivery mechanisms.
  • Merck
    Associate Principal Scientist, Vaccine Drug Product Development
    Merck Jul 2020 - Sep 2021
    Rahway, New Jersey, Us
    • Phase 2 through line-of-sight to commercial drug product process development. • Led the development of robust commercial lyophilization processes for single and multi-dose quadrivalent drug product presentations that achieved VVM7 requirements for distribution to the developing world.• Tech transfer of drug product processes to domestic and international commercial manufacturing partners and development of FSS and PPQ strategies.• Drug product development lead for authoring and source mapping clinical trial applications including Phase 2 IND.• CMC due diligence drug product development lead for evaluation of external technologies to support potential acquisitions.
  • Infectious Disease Research Institute
    Director, Process And Product Development
    Infectious Disease Research Institute Feb 2019 - Jul 2020
    • Managed a multidisciplinary team of twelve direct and indirect reports responsible for protein, RNA, VLP, and viral-vector vaccine development including bioprocess, formulation, and tech transfer to internal and external CMO sites. • Established self-amplifying mRNA vaccine platform including drug substance and drug product processes. • Developed and implemented new departmental formulation methodologies including Design of Experiments (DoE), high-throughput excipient screening (intrinsic fluorescence, extrinsic fluorescence, SLS), stress stability studies (shipping, photochemical, freeze/thaw, oxidative), and kinetic predictive storage stability modeling (AKTS-thermokinetics).• Responsible for CDMO management, site selection, due diligence visits, audit support, technology transfer, and manufacturing process oversite for cGMP activities including master cell bank (MCB), bulk drug substance (BDS), and final drug product (FDP) for recombinant protein-based pharmaceuticals.• Chaired a multi-institution CMC subcommittee responsible for vaccine development including analytical, formulation, process development, and management, site selections, and audits of CMOs, as part of the Global Health Vaccine Center for Innovation (GHVCI).• Program manager for departmental contract research and development projects including SOW writing, cost proposal development, timeline management, budget tracking, client communication, and technical project oversight. • Author of regulatory filings for CMC sections of multiple IND filings.
  • Infectious Disease Research Institute
    Senior Scientist, Process And Product Development Manager
    Infectious Disease Research Institute Feb 2016 - Jan 2019
  • Infectious Disease Research Institute
    Scientist Ii, Characterization And Product Development Manager
    Infectious Disease Research Institute Jul 2014 - Feb 2016
  • Infectious Disease Research Institute
    Scientist I/ Analytics Manager
    Infectious Disease Research Institute Aug 2012 - Jul 2014
  • University Of Kansas
    Postdoctoral Researcher
    University Of Kansas Apr 2011 - Oct 2012
    Lawrence, Ks, Us
    Russ Middaugh and David Volkin LabsDepartment of Pharmaceutical Chemistry
  • Texas A&M University
    Graduate Student
    Texas A&M University Aug 2005 - Mar 2011
    College Station, Tx, Us
    J. Martin Scholtz and C. Nick Pace LabProtein Solubility
  • Indiana University
    Reu Summer Intern
    Indiana University May 2004 - Aug 2004
    Bloomington, Indiana, Us

Ryan Kramer Skills

Protein Chemistry Protein Expression Protein Purification Biochemistry Life Sciences Molecular Biology Sds Page Fluorescence Uv/vis Circular Dichroism Fluorescence Spectroscopy Hplc Fplc Formulation Dls Western Blotting Purification Molecular Cloning Spectroscopy Biophysics Uv Vis Gel Electrophoresis Pcr Chromatography Mass Spectrometry Lc Ms Protein Characterization Characterization Formulation Development

Ryan Kramer Education Details

  • Texas A&M University
    Texas A&M University
    Biochemistry
  • Washington State University
    Washington State University

Frequently Asked Questions about Ryan Kramer

What company does Ryan Kramer work for?

Ryan Kramer works for Astrazeneca

What is Ryan Kramer's role at the current company?

Ryan Kramer's current role is Leader in Drug Product Design and Development; Vaccines, LNPs, Adjuvants, Biologics, Fill/Finish, early-stage through commercial development.

What is Ryan Kramer's email address?

Ryan Kramer's email address is ry****@****dri.org

What is Ryan Kramer's direct phone number?

Ryan Kramer's direct phone number is +120638*****

What schools did Ryan Kramer attend?

Ryan Kramer attended Texas A&m University, Washington State University.

What skills is Ryan Kramer known for?

Ryan Kramer has skills like Protein Chemistry, Protein Expression, Protein Purification, Biochemistry, Life Sciences, Molecular Biology, Sds Page, Fluorescence, Uv/vis, Circular Dichroism, Fluorescence Spectroscopy, Hplc.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.